Cytokines and Chemokines in Cerebral Malaria Pathogenesis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28775960)

Published in Front Cell Infect Microbiol on July 20, 2017

Authors

Josefine Dunst1,2,3, Faustin Kamena1,2,3, Kai Matuschewski1,2

Author Affiliations

1: Parasitology Unit, Max Planck Institute for Infection BiologyBerlin, Germany.
2: Institute of Chemistry and Biochemistry, Free UniversityBerlin, Germany.
3: Molecular Parasitology, Institute of Biology, Humboldt UniversityBerlin, Germany.

Articles cited by this

(truncated to the top 100)

Pattern recognition receptors and inflammation. Cell (2010) 21.05

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet (2005) 12.98

The pathogenic basis of malaria. Nature (2002) 10.44

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet (2010) 8.52

TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet (1990) 6.32

Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med (2002) 5.84

Immunity to malaria: more questions than answers. Nat Immunol (2008) 5.71

An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol (1994) 5.34

Malarial retinopathy: a newly established diagnostic sign in severe malaria. Am J Trop Med Hyg (2006) 5.14

Cytokines and endothelial cell biology. Physiol Rev (1990) 5.02

Evolving functions of endothelial cells in inflammation. Nat Rev Immunol (2007) 4.94

Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Am J Trop Med Hyg (2009) 4.79

The pathophysiology of vivax malaria. Trends Parasitol (2009) 4.57

Innate immunity to malaria. Nat Rev Immunol (2004) 4.19

Immune function of astrocytes. Glia (2001) 4.05

Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J Exp Med (2005) 3.85

Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care (2007) 3.80

Immunological processes in malaria pathogenesis. Nat Rev Immunol (2005) 3.80

Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome. Immunity (2011) 3.74

Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu Rev Microbiol (1997) 3.66

Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc Natl Acad Sci U S A (2007) 3.41

Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity. J Biol Chem (2004) 3.30

Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol (2003) 3.18

Chemokines and their receptors: drug targets in immunity and inflammation. Annu Rev Pharmacol Toxicol (2008) 3.04

A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol (2006) 2.90

Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites. J Exp Med (1993) 2.88

Severe malaria is associated with parasite binding to endothelial protein C receptor. Nature (2013) 2.86

The chemokine superfamily revisited. Immunity (2012) 2.83

Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications. Expert Rev Mol Med (2009) 2.77

Direct in vivo assessment of microcirculatory dysfunction in severe falciparum malaria. J Infect Dis (2008) 2.77

Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol (2014) 2.71

Perfusion abnormalities in children with cerebral malaria and malarial retinopathy. J Infect Dis (2009) 2.69

Development, maintenance and disruption of the blood-brain barrier. Nat Med (2013) 2.62

Reduced microcirculatory flow in severe falciparum malaria: pathophysiology and electron-microscopic pathology. Acta Trop (2004) 2.58

Cerebral malaria in children is associated with long-term cognitive impairment. Pediatrics (2008) 2.45

Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture. Clin Exp Immunol (1989) 2.41

Human malarial disease: a consequence of inflammatory cytokine release. Malar J (2006) 2.36

Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc Natl Acad Sci U S A (1992) 2.34

Malaria-infected erythrocyte-derived microvesicles mediate cellular communication within the parasite population and with the host immune system. Cell Host Microbe (2013) 2.29

Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol (1999) 2.29

Platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes is a common adhesive phenotype and is associated with severe malaria. Proc Natl Acad Sci U S A (2001) 2.27

Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparum-parasitized erythrocytes: a role for CD36 in malarial clearance. Blood (2000) 2.26

Potential role of MCP-1 in endothelial cell tight junction 'opening': signaling via Rho and Rho kinase. J Cell Sci (2003) 2.21

Evolutionary relatedness of Plasmodium species as determined by the structure of DNA. Science (1984) 2.16

Plasmodium falciparum-infected erythrocytes decrease the integrity of human blood-brain barrier endothelial cell monolayers. J Infect Dis (2007) 2.11

Immunopathogenesis of cerebral malaria. Int J Parasitol (2006) 2.08

Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc Natl Acad Sci U S A (2008) 2.08

Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J Immunol (1996) 2.07

Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection. Nat Med (2013) 2.06

Systemic endothelial activation occurs in both mild and severe malaria. Correlating dermal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity. Am J Pathol (1998) 2.05

Human cerebral malaria and the blood-brain barrier. Int J Parasitol (2006) 2.05

Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar J (2008) 2.00

Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res (2010) 1.98

Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar J (2007) 1.97

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial. Lancet Infect Dis (2015) 1.97

Pathogenesis of malaria and clinically similar conditions. Clin Microbiol Rev (2004) 1.87

Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J Exp Med (2002) 1.86

Malaria: mechanisms of erythrocytic infection and pathological correlates of severe disease. Annu Rev Pathol (2007) 1.83

Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infect (2002) 1.81

The role of animal models for research on severe malaria. PLoS Pathog (2012) 1.76

Blood-brain barrier function in cerebral malaria in Malawian children. Am J Trop Med Hyg (2001) 1.74

The cytokine theory of human cerebral malaria. Parasitol Today (1994) 1.73

Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children. N Engl J Med (2016) 1.73

Morphology and kinetics of the three distinct phases of red blood cell invasion by Plasmodium falciparum merozoites. Int J Parasitol (2008) 1.70

Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. Am J Trop Med Hyg (2008) 1.69

NK cells stimulate recruitment of CXCR3+ T cells to the brain during Plasmodium berghei-mediated cerebral malaria. J Immunol (2007) 1.69

Molecular aspects of severe malaria. Clin Microbiol Rev (2000) 1.64

The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J Infect Dis (1996) 1.62

IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection. PLoS Pathog (2009) 1.61

Clusters of cytokines determine malaria severity in Plasmodium falciparum-infected patients from endemic areas of Central India. J Infect Dis (2006) 1.57

Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur J Immunol (1997) 1.56

Glycosylphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway. J Immunol (1996) 1.54

Sequestration and microvascular congestion are associated with coma in human cerebral malaria. J Infect Dis (2011) 1.52

Malaria, the red cell, and the endothelium. Annu Rev Med (1994) 1.48

Plasmodium falciparum-infected erythrocytes induce NF-kappaB regulated inflammatory pathways in human cerebral endothelium. Blood (2009) 1.46

Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria. J Immunol (2011) 1.46

Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria. Eur J Immunol (1991) 1.42

Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency. J Immunol (2008) 1.42

Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation. PLoS Pathog (2010) 1.39

Murine cerebral malaria development is independent of toll-like receptor signaling. Am J Pathol (2007) 1.38

Uninfected erythrocytes form "rosettes" around Plasmodium falciparum infected erythrocytes. Am J Trop Med Hyg (1989) 1.37

Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect (1999) 1.37

Platelet factor 4 mediates inflammation in experimental cerebral malaria. Cell Host Microbe (2008) 1.34

Malaria's deadly grip: cytoadhesion of Plasmodium falciparum-infected erythrocytes. Cell Microbiol (2013) 1.34

Plasmodium falciparum-infected erythrocytes increase intercellular adhesion molecule 1 expression on brain endothelium through NF-kappaB. Infect Immun (2006) 1.34

IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain. J Immunol (2012) 1.34

Circulating red cell-derived microparticles in human malaria. J Infect Dis (2011) 1.30

The murine IL-8 homologues KC, MIP-2, and LIX are found in endothelial cytoplasmic granules but not in Weibel-Palade bodies. J Leukoc Biol (2009) 1.25

Neuropathogenesis of human and murine malaria. Trends Parasitol (2010) 1.24

TLR-mediated cell signaling by malaria GPIs. Trends Parasitol (2007) 1.24

Endothelial cell activation induced by tumor necrosis factor and lymphotoxin. Am J Pathol (1989) 1.23

Severe malaria in Cameroonian children: correlation between plasma levels of three soluble inducible adhesion molecules and TNF-alpha. Acta Trop (2007) 1.20

Cell biology and immunology of malaria. Immunol Rev (2011) 1.20

CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-gamma-induced chemokines. Eur J Immunol (2008) 1.20

MicroRNA-155 negatively affects blood-brain barrier function during neuroinflammation. FASEB J (2014) 1.19

An evolving new paradigm: endothelial cells--conditional innate immune cells. J Hematol Oncol (2013) 1.17

Plasmodium falciparum adhesion on human brain microvascular endothelial cells involves transmigration-like cup formation and induces opening of intercellular junctions. PLoS Pathog (2010) 1.16

Monocyte chemoattractant protein-1 alters expression of tight junction-associated proteins in brain microvascular endothelial cells. Microvasc Res (2004) 1.15

Vascular endothelial cells cultured from patients with cerebral or uncomplicated malaria exhibit differential reactivity to TNF. Cell Microbiol (2010) 1.15

Central nervous system in cerebral malaria: 'Innocent bystander' or active participant in the induction of immunopathology? Immunol Cell Biol (2001) 1.12